← All Sponsors
SPONSOR

Children's Cancer Group, China

Total Trials
1
Recruiting
1
Phases
Phase 2, Phase 3
Conditions studied: Classical Hodgkin LymphomaChildAdolescentYoung AdultMetabolic ResponseSurvivalTreatmentBrentuximab VedotinPET Scan
NCT06563245 Phase 2, Phase 3
Recruiting

Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment

Classical Hodgkin Lymphoma
China View Trial →